aminostigmine

Known as: Carbamic acid, dimethyl-, 2-((dimethylamino)methyl)-3-pyridinyl ester, dihydrochloride 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1991-2013
012319912013

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
We studied the effects of 2-(hexyl(methyl)amino)methyl)pyridyl-3-dimethyl carbamate (OPDC), a structural analogue of… (More)
  • table 1
  • figure 1
  • table 2
  • table 3
Is this relevant?
2004
2004
One of the esters of the patented group (N,N-dimethyl-(2-N',N'-dimethylaminomethylpyridyl-3)carbamate dihydrochloride) was… (More)
Is this relevant?
2004
2004
N,N-Dimethyl-(2-N,N-dimethylamino-3-methylpyridyl) carbamate hydrochloride (aminostigmine, I) belongs to the group of reversible… (More)
  • figure 2
  • figure 1
Is this relevant?
1998
1998
The results of studying the pharmacokinetics of aminostigmine, a new reversible cholinesterase inhibitor produced in Russia, are… (More)
Is this relevant?
1996
1996
The results of application of cholinesterase inhibitors, aminostigmin and galantamin, for treatment of acute poisoning with… (More)
Is this relevant?
1996
1996
Aminostigmin, a novel reversible inhibitor of cholinesterase developed in Russia, has been tried in management of poisoning with… (More)
Is this relevant?
1996
1996
The properties of aminostigmine in comparison with those of other carbamate inhibitors of cholinesterases have been studied in… (More)
Is this relevant?
1994
1994
Experiments on non-inbred albino mice have demonstrated that aminostigmine is an active reversible centrally active… (More)
Is this relevant?
1992
1992
The pharmacological properties of a new drug approved in the USSR for the treatment of cholinolytics poisonings are described… (More)
Is this relevant?
1991
1991
The effect of anesthesia with ketamine (80 mg/kg, intraperitoneally) combined with phenazepam (0.5 mg/kg, subcutaneously) on the… (More)
Is this relevant?